INTERNATIONAL PATENT: ASTRAZENECA AB FILES APPLICATION FOR "TREATMENT OF LIMITED-STAGE SMALL-CELL LUNG CANCER WITH PD-L1 INHIBITORS"

GENEVA, Oct. 13 -- ASTRAZENECA AB (SE-151-85 Sodertalje) filed a patent application (PCT/IB2025/053550) for "TREATMENT OF LIMITED-STAGE SMALL-CELL LUNG CANCER WITH PD-L1 INHIBITORS" on Apr 04, 2025. With publication no. WO/2025/210571, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JIANG, Haiyi (ASTRAZENECA PHARMACEUTICALS LPOne Medimmune WayGaithersburg, Maryland 20878), SHIRE, Norah (ASTRAZENECA PHARMACEUTICALS LPOne Medimmune WayGaithersburg, Maryland 20878)

Abstract: The disclosure relates to methods of treating lim...